He & She MD vs bmiMD: pricing, support, and commitment compared
If you want bundled coaching plus clinician messaging, He & She MD emphasizes app-based 1:1 clinician access with semaglutide starting at $139/month (intro rate). bmiMD focuses on compounded tirzepatide with multi month pricing down to $139/month for a 12 month plan. Early verdict: choose He & She MD for included coaching and clinician messaging; choose bmiMD for lower long term monthly cost on tirzepatide commitments.
Explore He & She MD plans and app features
Head to head: what differs most between He & She MD vs bmiMD
Direct comparison centers on three main differences supported in the sources: medication formats and focus, pricing structure and commitments, and bundled clinical support and app features. Each provider uses compounded GLP-1 or GLP-1/GIP medications and notes that compounded meds are not FDA approved or reviewed by the FDA for safety, effectiveness or quality.
Medication types and focus
He & She MD offers multiple formats: compounded semaglutide injection, oral semaglutide, and tirzepatide injection. bmiMD advertises compounded tirzepatide specifically. The evidence shows He & She MD positions a choice of semaglutide or tirzepatide formats, while bmiMD centers on tirzepatide as its GLP-1/GIP offering.
Pricing structure and commitments
He & She MD lists semaglutide injections starting at $139/month and oral semaglutide and tirzepatide at $199/month as six month introductory rates that renew higher. The source explicitly states these are six month intro rates that renew 30 to 45 percent higher and are structured as six month terms rather than month to month.
bmiMD provides tirzepatide pricing across four billing options: $179/month month to month; $159/month three month plan; $149/month six month plan; and $139/month 12 month plan. bmiMD advertises lower long term monthly equivalents but notes that the lowest price requires a 12 month commitment and that total prepaid charge should be confirmed.
Bundled support and clinician access
He & She MD bundles a coaching app with 1:1 clinician messaging, GLP-1 specific coaching and progress tracking at no extra cost. The source lists free expedited shipping, no membership fee, and no insurance needed. bmiMD offers 24/7 clinician access and free subscription shipping, with online refills and delivery. The difference is He & She MD emphasizes an included app with coaching and tracking while bmiMD emphasizes continuous clinician access and flexible billing options.
See bmiMD tirzepatide billing options
Side by side comparison table
| Criteria | He & She MD | bmiMD |
|---|---|---|
| Primary medications offered | Compounded semaglutide injection, oral semaglutide, tirzepatide injection | Compounded tirzepatide (GLP-1/GIP) |
| Starting price cited | Semaglutide from $139/month (six month intro rate) | Tirzepatide from $139/month with 12 month plan |
| Billing and commitment | Six month introductory terms; renew higher after six months | Four billing options: 1, 3, 6, 12 month plans; lowest price needs 12 month commitment |
| Clinical support | App with 1:1 clinician messaging, GLP-1 coaching and tracking included | 24/7 clinician access; online refills and delivery |
| Shipping and fees | Free expedited shipping; no membership fee; no insurance needed | Free subscription shipping; total prepaid charge should be confirmed |
| Regulatory note | Compounded meds not FDA reviewed for safety, effectiveness or quality | Compounded meds not FDA reviewed for safety, effectiveness or quality |
Practical scenarios and trade offs
Choose He & She MD if you want semaglutide options or a program that bundles a coaching app with 1:1 clinician messaging and progress tracking at no extra cost. The source frames He & She MD as suited to people wanting coaching and clinician access built into the plan rather than sold separately.
Compare He & She MD plan details
Choose bmiMD if your priority is the lowest long term monthly equivalent on tirzepatide and you are willing to commit to a multi month plan. The source highlights four billing choices with the lowest $139/month equivalent tied to a 12 month commitment and notes that total cost and state availability should be confirmed before enrollment.
Check bmiMD plan lengths and eligibility
Final comparison and recommendation
He & She MD vs bmiMD comes down to format and support versus long term per month cost on tirzepatide. He & She MD bundles app coaching, 1:1 clinician messaging, and multiple medication formats with six month intro pricing that renews higher. bmiMD centers on compounded tirzepatide with four billing options and lower monthly equivalents when you commit to longer plans. Both note that compounded medications are not FDA reviewed.
Choose He & She MD if you want bundled coaching and clinician messaging with semaglutide or tirzepatide formats. Choose bmiMD if you want the lowest long term monthly equivalent for tirzepatide and are prepared to commit to a multi month plan. This comparison reflects only the supplied source facts about He & She MD vs bmiMD.